Compounds > 3-iodobenzylguanidine
Page last updated: 2024-08-24

3-iodobenzylguanidine and Peripheral Nerve Neoplasms

3-iodobenzylguanidine has been researched along with Peripheral Nerve Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Jimenez, C; Lu, Y1
Jimenez, C; Lu, Y; Xu, G1
Bertolazzi, L; De Bernardi, B; Di Cataldo, A; Gambini, C; Garaventa, A; Haupt, R; Pizzitola, MR; Villavecchia, G1
Franzius, C; Hermann, K; Juergens, KU; Kopka, K; Schober, O; Vormoor, J; Weckesser, M1
de Kraker, J; Heij, HA; van Hasselt, EJ; Vos, A; Voûte, PA1

Other Studies

5 other study(ies) available for 3-iodobenzylguanidine and Peripheral Nerve Neoplasms

ArticleYear
Functional Imaging Evidence of Tumor Response to High-Specific-Activity 131 I-MIBG Therapy in an 84-Year-Old Patient With Metastatic Pheochromocytoma/Paraganglioma.
    Clinical nuclear medicine, 2023, May-01, Volume: 48, Issue:5

    Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged, 80 and over; Brain Neoplasms; Humans; Male; Neoplasms, Second Primary; Paraganglioma; Peripheral Nervous System Neoplasms; Pheochromocytoma

2023
Proposed MIBG Scan-Based Tumor Response Criteria of High-Specific-Activity 131 I-MIBG Therapy in Metastatic Pheochromocytoma/Paraganglioma.
    Clinical nuclear medicine, 2023, Apr-01, Volume: 48, Issue:4

    Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Brain Neoplasms; Humans; Neoplasms, Second Primary; Neuroendocrine Tumors; Paraganglioma; Peripheral Nervous System Neoplasms; Pheochromocytoma

2023
Second malignancies in children with neuroblastoma after combined treatment with 131I-metaiodobenzylguanidine.
    Cancer, 2003, Mar-01, Volume: 97, Issue:5

    Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Female; Humans; Hypothyroidism; Infant; Male; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Neuroblastoma; Peripheral Nervous System Neoplasms; Radiopharmaceuticals; Survival Rate; Treatment Outcome

2003
Whole-body PET/CT with 11C-meta-hydroxyephedrine in tumors of the sympathetic nervous system: feasibility study and comparison with 123I-MIBG SPECT/CT.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2006, Volume: 47, Issue:10

    Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Aged; Autonomic Nervous System Diseases; Carbon Radioisotopes; Child; Child, Preschool; Ephedrine; Feasibility Studies; Female; Humans; Infant; Iodine Radioisotopes; Male; Middle Aged; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Whole Body Imaging

2006
Pretreatment with [131I] metaiodobenzylguanidine and surgical resection of advanced neuroblastoma.
    European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie, 1996, Volume: 6, Issue:3

    Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Antineoplastic Agents; Child; Child, Preschool; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neoplasm Staging; Neuroblastoma; Peripheral Nervous System Neoplasms; Radiotherapy, Adjuvant; Survival Rate; Sympathetic Nervous System

1996